Alex Brill is a research fellow at the American Enterprise Institute (AEI), where he studies the impact of tax policy on the US economy as well as the fiscal, economic, and political consequences of tax, budget, health care, retirement security, and trade policies. He also works on health care reform, pharmaceutical spending and drug innovation, and unemployment insurance reform. Brill is the author of a pro-growth proposal to reduce the corporate tax rate to 25 percent, and “The Real Tax Burden: More than Dollars and Cents” (2011), coauthored with Alan D. Viard. He has testified numerous times before Congress on tax policy, labor markets and unemployment insurance, Social Security reform, fiscal stimulus, the manufacturing sector, and biologic drug competition.
Before joining AEI, Brill served as the policy director and chief economist of the House Ways and Means Committee. Previously, he served on the staff of the White House Council of Economic Advisers. He has also served on the staff of the President's Fiscal Commission (Simpson-Bowles) and the Republican Platform Committee (2008).
Brill has an M.A. in mathematical finance from Boston University and a B.A. in economics from Tufts University.
Tax season is over for all but the greatest procrastinators among us. Two-thirds of taxpayers are celebrating their forthcoming refunds while tens of millions of others have grudgingly written a check to the IRS.
The recent Senate agreement on unemployment benefits combines two big policy mistakes: a corporate welfare provision that lets employers underfund their workers’ pensions and a (largely retroactive) extension of unemployment benefits that does nothing to cure the long-term unemployment crisis.
After 50 years of the War on Poverty, we have neither a clearly defined mission nor a consensus on policy options. We don’t even have a good way to measure poverty. President Obama’s fiscal year 2015 budget is an example of the jumble that U.S. anti-poverty efforts have become, featuring both ill-conceived and promising policies
A new regulation proposed by the Food and Drug Administration will compel generic drug makers to update their labels to reflect “new” safety issues. This new rule is a poor tool for keeping generic drug labels up-to-date, and it will come at a significant cost to consumers. If public health is the true imperative for this change, the FDA can address the generic labeling issues in far better ways.
Yesterday, House Ways and Means Committee Chairman Dave Camp (R-Michigan) unveiled the most sweeping, elaborate, and aggressive income tax reform proposal in a generation. His plan is the result of years of effort that have included bipartisan outreach, dozens of hearings, and thousands of hours of staff time. He...
For more than five years, the federal government has provided extended unemployment benefits to workers who have lost their jobs through no fault of their own and remained out of work beyond the standard 26 weeks of unemployment benefits.
At the Philanthropic Freedom Project's inaugural public event, AEI President Arthur Brooks will present his new research on how charitable giving has changed in the United States in the wake of the Great Recession and how those changes have serious ramifications for future tax policy.